<DOC>
	<DOCNO>NCT00001870</DOCNO>
	<brief_summary>Diabetes disease characterize decreased sensitivity action insulin promote sugar ( glucose ) use blood vessel relaxation ( vasodilation ) muscle . Insulin 's ability cause blood vessel relaxation control , part , nitric oxide ( NO ) . Nitric oxide substance produce cell line blood vessel wall ( endothelium ) . Increased blood flow muscle account increase sugar ( glucose ) area body . Therefore , cell blood vessel wall ( endothelium ) function properly may contribute insulin resistance . Injections Vitamin C directly arteries show improve blood vessel reaction nitric oxide diabetic patient . Researchers believe may due Vitamin C 's ability increase level nitric oxide blood vessel . The goal study determine effect vitamin C insulin sensitivity endothelium function patient type 2 diabetes . An additional goal study determine effect vitamin C patient vitamin C deficiency . Patients participate study undergo series testis determine insulin sensitivity blood vessel reactivity . Patients divide two group . One group receive dose oral vitamin C. The group receive dos placebo ( inactive pill contain vitamin C ) . Patients receive medication four week test insulin sensitivity blood vessel reactivity . Researchers believe dose vitamin C diabetic patient vitamin C deficiency improve insulin sensitivity function endothelium . Results gather form study may provide information vitamin C level diabetic may lead development new therapy treat insulin resistance endothelium dysfunction .</brief_summary>
	<brief_title>Study Effects Vitamin C Patients With Type 2 Diabetes</brief_title>
	<detailed_description>Diabetes characterize decreased sensitivity action insulin promote glucose utilization vasodilation skeletal muscle bed . Insulin 's vasodilator action mediate , part , endothelial-derived nitric oxide ( NO ) . Increased blood flow account approximately 25 % increase skeletal muscle glucose disposal mediate insulin . Therefore , endothelial dysfunction may contribute insulin resistance . Intraarterial administration vitamin C improve NO-dependent vascular reactivity diabetic subject ( normal subject ) . This may due antioxidant property vitamin C result relative increase level NO diabetic vasculature . In exploratory protocol , primary objective ass effect oral administration vitamin C insulin sensitivity endothelial function subject type 2 diabetes . A secondary , peripheral objective , study effect vitamin C-deficient clinical research volunteer . Hyperinsulinemic euglycemic glucose clamp procedure forearm blood flow measurement use assess insulin sensitivity vascular reactivity diabetic subject clinical research volunteer plasma vitamin C level less 30 microM . The subject give either placebo oral vitamin C supplementation ( 800 mg/day ) four week assessment insulin sensitivity vascular reactivity repeat . Plasma level vitamin C measure confirm subject experimental group appropriate increase vitamin C level . We hypothesize chronic oral administration vitamin C diabetic clinical research volunteer deficient vitamin C improve insulin sensitivity endothelial function . Our study provide information vitamin C level diabetic subject may suggest potential therapy significantly improve endothelial dysfunction insulin resistance .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Acetylcholine</mesh_term>
	<criteria>INCLUSION CRITERIA : DIABETIC SUBJECTS : Males nonpregnant female age 18 65 good general health except type 2 diabetes control diet and/or oral hypoglycemic agent . Patients find plasma vitamin C level less 40 microliter M , enrol protocol take hypoglycemic agent approximately one week prior study . VITAMIN CDEFICIENT CLINICAL RESEARCH VOLUNTEERS : Adults age 18 35 good general health drug medication . EXCLUSION CRITERIA : ALL SUBJECTS : Pregnancy , liver disease , pulmonary disease , renal insufficiency , coronary heart disease , heart failure , peripheral vascular disease , coagulopathy , disease predispose vasculitis Raynaud 's phenomenon , bleed disorder , kidney stone , glucose6phosphate dehydrogenase deficiency , family history hemochromatosis/iron overload , platelet count le 150,000/ml blood , prothrombin time/partial thromboplastin time ( PT/PTT ) great 1 second normal range , inability give inform consent procedure , positive test HIV , hepatitis B C. DIABETIC SUBJECTS : In addition , exclusion criterion , presence proteinuria great 500 mg/24 hr , proliferative retinipathy , diabetic neuropathy VITAMIN CDEFICIENT CLINICAL RESEARCH VOLUNTEERS : All exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2004</verification_date>
	<keyword>Insulin Resistance</keyword>
	<keyword>Oxidative Stress</keyword>
	<keyword>Antioxidant</keyword>
	<keyword>Endothelial Function</keyword>
	<keyword>Glucose Clamp</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Vitamin C Deficiency</keyword>
</DOC>